Chemotherapy post-surgery ‘may not be always necessary’November 9th, 2010 - 4:51 pm ICT by ANI
London, Nov 9 (ANI): NRC researchers have developed a tool to determine which breast cancer patients have little risk of their disease recurring, which has the potential to virtually eliminate unnecessary chemotherapy.
They have found that for most patients with early stage breast cancer, chemotherapy following surgery is totally unnecessary and therefore does more harm than good.
Side effects of breast cancer chemotherapy range from nausea, vomiting and hair loss to mouth sores, menopause, infertility, numbness and aching of the joints, hands and feet.
The tool is an algorithm that identifies “gene expression signatures” or biomarkers that can predict low risk tumours with 87-100 percent accuracy in different groups of patients.
To conduct their study, Dr. Edwin Wang and his colleagues at the NRC Biotechnology Research Institute in Montreal used published data on gene expression profiles from more than 1000 breast cancer samples.
“Every tumour has a gene expression profile, which indicates how the patient’s genes have changed,” Wang said.
“We combined this data with information on the patient’s outcome - such as whether the original tumour spread and how long the person survived - to develop our algorithm,” he added.
The NRC team now hopes to see its algorithm applied in a clinical setting.
“We have a provisional patent on the intellectual property and we would like to get a Canadian company to license it and turn it into a kit format,” said Dr. Maureen O’Connor of NRC-BRI, who co-authored the study.
The study appeared in a recent issue of Nature Communications. (ANI)
- New test to better predict breast cancer outcomes discovered - Jan 28, 2011
- Gene discovery could guide future breast cancer treatment choices - Jan 25, 2010
- 'Wonderdrug' keeps breast cancer away - Feb 25, 2011
- Genetic changes linked to diet, alcohol could predict breast cancer severity - Jul 31, 2010
- Combo therapy may overcome Herceptin-resistant breast cancer - Mar 14, 2011
- Intestinal stem cells offer clues to colon cancer origin and relapse - Mar 18, 2011
- Gene test may bring safe chemotherapy - Mar 23, 2012
- New drug may help cure breast and ovarian cancer - Jul 07, 2010
- Simple genetic test may lead to more personalized breast cancer treatment - May 07, 2010
- Circulating tumour cells in blood up death risk in early-stage breast cancer patients - Dec 11, 2010
- Oz scientists' defective gene discovery solves colorectal cancer mystery - Jan 17, 2011
- New gene may lead to personalized ovarian cancer treatment - Dec 09, 2009
- Chemo plus tamoxifen beneficial for some breast cancer patients - Dec 11, 2009
- FDA approves personalized therapy for tough-to-treat colorectal cancer - Jul 26, 2012
- Indian-origin scientist's finding offers hope for advanced cancer patients - Apr 06, 2011
Tags: biomarkers, biotechnology research institute, breast cancer, breast cancer chemotherapy, breast cancer patients, bri, chemotherapy, effects of breast cancer, gene expression profile, gene expression profiles, hands and feet, mouth sores, nausea vomiting, nrc team, numbness, o connor, provisional patent, stage breast cancer, tumour, tumours